HMGB1 could not be identified as an effective predictive factor for CRT, because only tumor tissues obtained after CRT were used for immunohistochemical staining of HMGB1, and immunostaining of HMGB1 may be affected by CRT itself. Here, HMGB1 is linked to neoplasm.